Skip to main content

Joan Genescà Ferrer

Internal medicine doctor expert in hepatology. Special dedication to advanced liver disease, liver cirrhosis and portal hypertension. Interest in non-invasive methods for the diagnosis and control of liver disease, especially liver elastography. Both clinical and experimental research in animal models of liver disease, including therapeutic studies with nanomedicine.

Institutions of which they are part

Head of group
Liver Diseases
Vall Hebron Institut de Recerca
Hepatologia
General Hospital

Joan Genescà Ferrer

Institutions of which they are part

Head of group
Liver Diseases
Vall Hebron Institut de Recerca
Hepatologia
General Hospital

Internal medicine doctor expert in hepatology. Special dedication to advanced liver disease, liver cirrhosis and portal hypertension. Interest in non-invasive methods for the diagnosis and control of liver disease, especially liver elastography. Both clinical and experimental research in animal models of liver disease, including therapeutic studies with nanomedicine.

Chief Liver Unit.
Clinical director of Digestive Diseases.
Professor of Medicine of the UAB.

Projects

Papel de la elastografía hepática y esplénica en el diagnóstico, seguimiento y tratamiento de la enfermedad crónica hepática avanzada.

IP: Joan Genescà Ferrer
Collaborators: Mònica Pons Delgado
Funding agency: Instituto de Salud Carlos III
Funding: 82400
Reference: FI14/00152
Duration: 01/01/2015 - 31/12/2018

Integrated Approaches for Identifying Molecular Targets in Alcoholic Hepatitis Molecular Subtypes for Targeted Therapies in Alcoholic Hepatittis U01 AA021908-01

IP: Victor Manuel Vargas Blasco
Collaborators: Joan Genescà Ferrer
Funding agency: National Institutes of Health (NIH)
Funding: 94320
Reference: INTEAM_NIH-NIAAA2013
Duration: 01/06/2013 - 31/12/2018

Malalties hepàtiques

IP: Joan Genescà Ferrer
Collaborators: -
Funding agency: Instituto de Salud Carlos III
Funding: 135000
Reference: JR13/00023
Duration: 01/04/2014 - 31/03/2017

Preventing cardiovascular ischemic events and arresting their consequences in type 2 diabetic population: a multidisciplinary clinical and experimental approach

IP: -
Collaborators: Ignacio Ferreira González, José Antonio Barrabés Riu, Bustamante Rangel, Alejandro, Joan Montaner Villalonga, Immaculada Raurell Saborit, Joan López Hellin, Antonio González Fernández, Antonia Sambola Ayala, Marta García Ramírez, Joaquin Lopez Soriano, Anna Meseguer Navarro, Antonio Rodríguez Sinovas, Artur Evangelista Masip, Rafael Simó Canonge, Santiago Aguade Bruix, Francesc Moreso Mateos, Cristina Hernández Pascual, Anna Penalba Morenilla, Maria Nieves Martell Pérez-Alcalde, Neus Bellera Gotarda, Natalia Ramos Terrades, Andreea Ciudin Mihai, Maria Mar Hernandez Guillamon, Yolanda Riba Llena, Meritxell Ibernon Vilaró, Ignasi Barba Vert, Jordi Bañeras Rius, Bruno García del Blanco, Daniel Serón Micas, María Eugenia Espinel Garuz, Marisol Ruiz Meana, Maria Pilar Delgado Martínez, Irene Montllor Ramoneda, Irina Betsabe Torres Rodriguez, Javier Inserte Igual, Anna Rosell Novel, Olga Simó Servat, Joan Genescà Ferrer, Mònica Pons Delgado, M Antonieta Azancot Rivero, Maria Nazarena Pizzi, M Antonieta Azancot Rivero
Funding agency: Instituto de Salud Carlos III
Funding: 825000
Reference: PIE13/00027
Duration: 01/01/2014 - 30/06/2018

Related news

Preliminary study results confirm that the drug resmetirom reduces the presence of fat, inflammation, cell damage and fibrosis in the liver.

The European project, in which Vall d'Hebron participates, will favor personalized diagnosis and innovative therapeutic strategies in patients with the disease.

The research team used nanotechnology to deliver the drug directly to liver cells, which eliminated side effects without reducing effectiveness.

Related professionals

Laura Vidal Piñeiro

Laura Vidal Piñeiro

Research technician
Hepato-bilio-pancreatic surgery (HBP) and liver transplantation
Read more
Mireia Verdaguer Tremolosa

Mireia Verdaguer Tremolosa

Research technician
General Surgery
Read more
Montse  Adell  Trape

Montse Adell Trape

General Surgery
Read more
Marta  Marin  Soro

Marta Marin Soro

Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.